Peripartum management of glycemia in women with type 1 diabetes

Diabetes Care

Volumn 37, Issue 2, 2014, Pages 364-371

  Achong, Naomi ^a   Duncan, Emma L ^a   McIntyre, H David ^a   Callaway, Leonie ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INSULIN; LONG ACTING INSULIN; GLUCOSE BLOOD LEVEL;

ARTICLE; AUSTRALIA; BODY MASS; CONTINUOUS INFUSION; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DELIVERY; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PERINATAL PERIOD; PREGNANCY; PUERPERIUM; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; ADULT; AGED; BLOOD; DIABETES MELLITUS, TYPE 1; METABOLISM; PREGNANCY IN DIABETICS; PROSPECTIVE STUDY;

ADULT; AGED; AUSTRALIA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; INSULIN; PERIPARTUM PERIOD; PREGNANCY; PREGNANCY IN DIABETICS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 84893128062     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1348     Document Type: Article

References (39)

1. The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. Ann Intern Med 1998;128:517-523
2. Carron Brown S, Kyne-Grzebalski D, Mwangi B, Taylor R. Effect of management policy upon 120 type 1 diabetic pregnancies: policy decisions in practice. Diabet Med 1999;16:573-578
3. Curet LB, Izquierdo LA, Gilson GJ, Schneider JM, Perelman R, Converse J. Relative effects of antepartum and intrapartum maternal blood glucose levels on incidence of neonatal hypoglycemia. J Perinatol 1997; 17:113-115
4. Miodovnik M, Mimouni F, Tsang RC, et al. Management of the insulin-dependent diabetic during labor and delivery. Influences on neonatal outcome. Am J Perinatol 1987;4:106-114
5. Stenninger E, Lindqvist A, Aman J, Ostlund I, Schvarcz E. Continuous Subcutaneous Glucose Monitoring System in diabetic mothers during labour and postnatal glucose adaptation of their infants. Diabet Med 2008;25:450-454
6. Ornoy A. Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes. Pediatr Endocrinol Rev 2005;3:104-113
7. Stenninger E, Flink R, Eriksson B, Sahlèn C. Long-term neurological dysfunction and neonatal hypoglycaemia after diabetic pregnancy. Arch Dis Child Fetal Neonatal Ed 1998;79:F174-F179
8. West TE, Lowy C. Control of blood glucose during labour in diabetic women with combined glucose and low-dose insulin infusion. BMJ 1977;1:1252-1254
9. Grant E, Joshi GP. Glycemic control during labor and delivery: a survey of academic centers in the United States. Arch Gynecol Obstet 2012;285:305-310
10. Yudkin JS, Knopfler A. Glucose and insulin infusions during labour. Lancet 1992;339:1479
11. Caplan RH, Pagliara AS, Beguin EA, et al. Constant intravenous insulin infusion during labor and delivery in diabetes mellitus. Diabetes Care 1982;5:6-10
12. Jovanovic L, Nakai Y. Successful pregnancy in women with type 1 diabetes: from preconception through postpartum care. Endocrinol Metab Clin North Am 2006;35: 79-97, 6
13. Lean ME, Pearson DW, Sutherland HW. Insulin management during labour and delivery in mothers with diabetes. Diabet Med 1990;7:162-164
14. Lepercq J, Abbou H, Agostini C, et al. A standardized protocol to achieve normoglycaemia during labour and delivery in women with type 1 diabetes. Diabetes Metab 2008;34:33-37
15. Barrett HL, Morris J, McElduff A. Watchful waiting: a management protocol for maternal glycaemia in the peripartumperiod. Aust N Z J Obstet Gynaecol 2009;49:162-167
16. de Valk HW, Visser GH. Insulin during pregnancy, labour and delivery. Best Pract Res Clin Obstet Gynaecol 2011;25:65-76
17. Haigh SE, Tevaarwerk GJ, Harding PE, Hurst C. A method for maintaining normoglycemia during labour and delivery in insulin-dependent diabetic women. Can Med Assoc J 1982;126:487-490
18. Rosenberg VA, Eglinton GS, Rauch ER, Skupski DW. Intrapartum maternal glycemic control in women with insulin requiring diabetes: a randomized clinical trial of rotating fluids versus insulin drip. Am J Obstet Gynecol 2006;195:1095-1099
19. Hanson U, Moberg P, Efendic S. Dosage of insulin during delivery and the immediate post-partum period in pregnant diabetics. Acta Obstet Gynecol Scand 1981;60:183-186
20. Soler NG, Malins JM. Diabetic pregnancy: management of diabetes on the day of delivery. Diabetologia 1978;15:441-446
21. Golde SH, Good-Anderson B, Montoro M, Artal R. Insulin requirements during labor: a reappraisal. Am J Obstet Gynecol 1982; 144:556-559
22. Feldberg D, Dicker D, Samuel N, Peleg D, Karp M, Goldman JA. Intrapartum management of insulin-dependent diabetes mellitus (IDDM) gestants. A comparative study of constant intravenous insulin infusion and continuous subcutaneous insulin infusion pump (CSIIP). Acta Obstet Gynecol Scand 1988; 67:333-338
23. Jovanovic L, Peterson CM. Insulin and glucose requirements during the first stage of labor in insulin-dependent diabetic women. Am J Med 1983;75:607-612
24. Crombach G, Siebolds M, Mies R. Insulin use in pregnancy. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1993; 24:89-100
25. Maheux PC, Bonin B, Dizazo A, et al. Glucose homeostasis during spontaneous labor in normal human pregnancy. J Clin Endocrinol Metab 1996;81:209-215
26. Kjos SL. Postpartum care of the woman with diabetes. Clin Obstet Gynecol 2000;43:75-86
27. Njenga E, Lind T, Taylor R. Five year audit of peripartum blood glucose control in type 1 diabetic patients. DiabetMed 1992;9:567-570
28. Hare JW. Insulin management of type I and type II diabetes in pregnancy. Clin Obstet Gynecol 1991;34:494-504
29. Binder C, Lauritzen T, Faber O, Pramming S. Insulin pharmacokinetics. Diabetes Care 1984;7:188-199
30. Home PD. The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences. Diabetes Obes Metab 2012;14:780-788
31. Morello CM. Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus. Int J Gen Med 2011;4:827-835
32. Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care 1993;16(Suppl. 3): 155-165
33. Ilic S, Jovanovic L, Wollitzer AO. Is the paradoxical first trimester drop in insulin requirement due to an increase in C-peptide concentration in pregnant type 1 diabetic women? Diabetologia 2000;43:1329-1330
34. Murphy HR, Elleri D, Allen JM, Simmons D, Nodale M, Hovorka R. Plasma C-peptide concentration in women with type 1 diabetes during early and late pregnancy. Diabet Med 2012;29:e361-e364
35. Nielsen LR, Rehfeld JF, Pedersen-Bjergaard U, Damm P, Mathiesen ER. Pregnancy-induced rise in serum C-peptide concentrations in women with type 1 diabetes. Diabetes Care 2009;32:1052-1057
36. Nordisk, N. Levemir (insulin detemir [rDNA origin] injection) (prescribing information), 2010. Available from www.novo-pi.com/levemir.pdf. Accessed 5 October 2013
37. Sanofi. Lantus (insulin glargine [rDNA origin] injection) (prescribing information), 2007. Available from http:productions.sanofi.us/lantus/lantus. html. Accessed 5 October 2013
38. McElduff A, Cheung NW, McIntyre HD, et al.; Australasian Diabetes in Pregnancy Society. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Med J Aust 2005;183:373-377
39. Davison JM, Hytten FE. The effect of pregnancy on the renal handling of glucose. Br J Obstet Gynaecol 1975;82:374-381